Back to news

Comar Announces Expansion to Meet Growing Dropper Assembly Demand

January 13, 2020

Comar, a premier plastic packaging, device and component supplier, innovating solutions for customers who lead the way to a healthier world, is pleased to announce a major capacity expansion to support sustained growth in its dropper assembly product line.

Dropper assemblies are often used to dispense high-value products that can be viscous or fluid in consistency and come in a large variety of configurations based on end use and functional criteria like bottle size and ingredients. Component options include:

  •   Pipette substrate (glass or plastic), length, diameter, and tip shape
  •   Bulb substrate (rubber or TPE), size, color, and features
  •   Closure size, color, CR Function, and features
  •   Other decorative features such as overshelled closure
  •   Custom printing or a choice of stock dies
  •   CE registration
  •   Packaging options (poly wrap, shrink wrap, or blister packed)

Comar has been a leading supplier of dropper assemblies in North American for the past 30 years. Over that time, Comar built a unique and unmatched library of injection molds to produce hundreds of components and over 1,700 unique SKU combinations. Historical demand for dropper assemblies has been rather steady over the past 10 to 15 years, with some market growth off-set by the conversion of many Rx and OTC drug products moving into Comar’s more precise Oral Syringe. In recent months, a combination of market developments has spiked dropper demand to unprecedented levels. The market is being influenced by macro-economic factors such as an aging population and more adoption and promotion of high-end health and beauty skin care serums, the emergence of cannabidiol (CBD) tinctures, and supply chain strategies in favor of regional supply versus global. Underpinning these growth categories are steady demand for applications of dropper assemblies in the medical diagnostics, pharmaceutical, and food & beverage segments. This significant and sustained increase in demand is being felt on a global scale and manufacturers could not react fast enough.

“We’ve been challenged to keep up with the increase in demand but are very pleased to announce plans to increase capacity across all components via investments in additional injection molding machines, glass pipette forming machines, and additional molds and assembly equipment. Many of these investments will be completed in Q1 2020 and by 2021 we expect full implementation that will increase our capacity by up to 60%” said Mike Ruggieri, CEO at Comar.  In addition to in-house capacity expansion, Comar is working with component suppliers to ensure right-sized capacity to support growth and more collaborative supply chain to shorten lead times.

“We are thankful for our customers resilience and patience while working with us through existing lead time challenges. Looking forward, we are confident that these investments will improve our service levels and offer enhanced flexibility to support the highly fragmented and complex nature of the product line while balancing extreme volatility in demand” said Scott Conklin, EVP Sales & Marketing at Comar

RECENT NEWS

June 5, 2024

Comar Celebrates 75 Years of Innovation

Comar proudly announces its 75th anniversary as a leading contract manufacturer for healthcare companies worldwide and as a leading provider of primary packaging and dispensing products. Founded on the guiding principles of excellence, dedication, and customer-centricity, Comar has established itself as a trusted partner for clients in the Medical, Pharmaceutical, Consumer Healthcare, Personal & Home

Read more

May 28, 2024

Comar Achieves CE Certification for Medical Devices Under New EU MDR Regulations

Comar, a leading provider of innovative medical devices and packaging solutions, is thrilled to announce a significant achievement. After rigorous preparation, they successfully obtained their CE certificate under the latest EU Medical Device Regulations (EU MDR 2017/745). This certification is a significant milestone, marking Comar’s compliance with the latest European Union medical device standards. The

Read more

September 28, 2022

Comar Announces Brian Larkin as President and Chief Executive Officer

Comar has named Brian Larkin as its new President and Chief Executive Officer, succeeding Mike Ruggieri, who will transition to the Chairman role and remain on the Board of Directors. Under Mr. Ruggieri’s 15 years of leadership, Comar evolved from a single site family-owned business to a professionally backed, multi-national company with expanded customer relationships,

Read more